Tas2r113 is a recombinant protein expressed in multiple host systems, including mammalian cells (e.g., HEK293), E. coli, and rodent cell lines. Key structural features include:
Tags: His-tag, Avi-tag, and Fc-tag variants for purification and immobilization .
Length: Full-length (1–309 amino acids) or partial constructs, depending on expression systems .
Function: Exhibits G-protein-coupled receptor activity and signal transducer activity, facilitating intracellular signaling cascades upon ligand binding .
Tas2r113 participates in the taste transduction pathway, interacting with proteins such as:
| Pathway Component | Function |
|---|---|
| TAS2R40 | Bitter taste receptor |
| ITPR3 | Intracellular calcium signaling |
| PRKACA | Protein kinase A activation |
Recombinant Tas2r113 is commercially available in diverse formats:
Tas2r113 is expressed in gustatory tissues (e.g., posterior tongue papillae) and non-gustatory organs like the testis and heart. In mice, its expression in gustatory cells is moderate compared to highly expressed receptors such as Tas2r118 .
Gustatory Tissue: Detected in vallate papillae via in situ hybridization, though less abundant than Tas2r105 or Tas2r108 .
Non-Gustatory Tissue: Exhibits higher expression in testis, suggesting potential roles beyond taste perception .
While Tas2r113 has been identified as a functional bitter receptor, its specific agonists remain poorly characterized. Comparative studies highlight:
Tas2r113 is utilized in:
Tas2r113 is a member of the taste receptor type 2 (Tas2r) family, which functions as bitter taste receptors in vertebrates. In rats, as in other rodents, these G protein-coupled receptors are primarily expressed in taste receptor cells and mediate bitter taste perception by recognizing bitter compounds and initiating signaling cascades.
Tas2r receptors in rodents, including rats, exhibit variable expression levels in taste tissues. Some Tas2r family members, including Tas2r113, have been observed to have differential expression patterns across tissues. While primarily associated with gustatory function, Tas2r113 has shown notable expression in extra-oral tissues such as testis, suggesting additional physiological roles beyond taste perception .
Quantitative expression analyses of rodent Tas2r genes have revealed variable expression levels across different receptor subtypes. In mouse studies, which provide insight into rat receptor patterns due to evolutionary conservation, some Tas2r receptors show abundant expression in taste tissues while others demonstrate lower expression levels.
Interestingly, Tas2r113 has been observed to have relatively high expression in non-gustatory tissues such as testis, while showing low to moderate expression in gustatory tissue. This contrasts with other Tas2r family members that may show opposite expression patterns, suggesting differential regulation of Tas2r genes across tissues .
Recombinant Tas2r113 is typically produced using heterologous expression systems, most commonly in HEK293 cells (human embryonic kidney cells). The process involves:
Cloning the rat Tas2r113 gene into an appropriate expression vector
Transfecting the construct into HEK293 cells
Culturing the cells to express the recombinant protein
Harvesting and purifying the protein using affinity tags (commonly His-tags)
Confirming expression through Western blotting or functional assays
Similar to other recombinant taste receptors, the protein can be produced with various tags for detection, purification, or coupling to substrates such as magnetic beads, as seen with related Tas2r family members .
Functionally characterizing Tas2r113 presents several research challenges:
Co-expression requirements: Like other bitter taste receptors, Tas2r113 may require co-expression with signaling components such as Gα-gustducin or chimeric G proteins (e.g., Gα16gust44) in heterologous expression systems to achieve proper coupling and signal transduction.
Receptor sensitivity differences: Experimental methodology significantly impacts detection sensitivity. For example, studies with the related Tas2r105 revealed discrepancies in agonist profiles when using different G protein subunits. Cells expressing Gα16gust44 showed higher sensitivity than those expressing Gα15, allowing detection of low-efficacy activators that might be missed in less sensitive systems .
Proper trafficking: Ensuring proper membrane localization of the recombinant receptor can be challenging, often requiring optimization of expression constructs.
Agonist identification: The broad and sometimes overlapping agonist profiles of Tas2r receptors make it difficult to identify specific ligands for individual receptors like Tas2r113.
Researchers should consider these factors when designing functional characterization experiments for Tas2r113 to avoid false negative results or incomplete agonist profiles.
Based on comparative studies of bitter taste receptors across species, there are important considerations when comparing rat Tas2r113 with human orthologs:
Sequence-function relationships: Despite high sequence similarity between orthologs, functional studies of bitter taste receptors have revealed that even minor differences in amino acid sequences can substantially alter agonist profiles. Structure-function analyses of human TAS2Rs show that few amino acid differences can account for largely deviating agonist spectra .
Evolutionary adaptations: Species-specific bitter taste receptor profiles likely evolved in response to different ecological niches and dietary exposures to bitter compounds.
Ortholog identification challenges: True functional orthologs should recognize the same bitter compounds, but this cannot be reliably predicted based solely on sequence identity. Experimental validation is necessary to establish functional orthology.
Resolving contradictions in Tas2r113 functional data requires systematic methodological approaches:
Standardized expression systems: Adopt consistent heterologous expression systems with standardized G protein coupling partners. The choice between Gα15, Gα16, or chimeric Gα16gust44 significantly impacts detection sensitivity .
Dose-response analysis: Complete dose-response relationships should be established rather than single-concentration screenings, which may miss low-efficacy agonists.
Multiple readout systems: Employ complementary assays such as calcium imaging, cAMP measurements, and β-arrestin recruitment to comprehensively characterize receptor function.
Protein expression verification: Quantify surface expression levels across studies to normalize functional data and account for expression-dependent effects.
Inter-laboratory validation: Conduct parallel testing across different laboratories using standardized protocols and compound libraries.
When contradictions are observed, structured analysis approaches that systematically compare experimental conditions can identify the source of discrepancies, similar to contradiction detection methodologies used in other scientific domains .
For optimal functional studies of recombinant Tas2r113, researchers should consider the following expression system parameters:
Cell Line Selection:
HEK293T cells are most commonly used due to their high transfection efficiency and robust expression of GPCRs
CHO cells provide an alternative with different glycosylation patterns
Inducible expression systems may be beneficial for potentially toxic or low-expressing receptors
Expression Vector Components:
Strong promoters (CMV) for high expression levels
Codon optimization for rat proteins expressed in mammalian cells
N-terminal tags: Inclusion of the first 45 amino acids of rat somatostatin receptor 3 may improve membrane targeting
C-terminal epitope tags (e.g., FLAG, His) for detection and purification
Co-expression Components:
Gα16gust44 chimeric G protein for optimal coupling efficiency
Promiscuous G proteins to enhance signal detection sensitivity
In cases of poor surface expression, chaperone proteins may improve trafficking
Based on experiments with related Tas2r family members, the Gα16gust44 system demonstrates superior sensitivity for detecting low-efficacy agonists compared to Gα15-based assays, making it the preferred choice for comprehensive agonist profiling .
A multi-modal approach to analyzing Tas2r113 expression provides the most comprehensive characterization:
Quantitative RT-PCR (qRT-PCR):
Design primer pairs specific to Tas2r113, avoiding cross-reactivity with other Tas2r family members
Include reference genes (e.g., GAPDH, β-actin) for normalization
Compare expression levels to known markers such as α-gustducin to establish relative abundance
In Situ Hybridization:
Use digoxigenin-labeled riboprobes specific to Tas2r113
Perform parallel staining with sense probes as negative controls
Combine with immunohistochemistry for cell-type markers to identify specific expressing populations
RNA-Seq:
For unbiased transcriptomic profiling across tissues
Provides insight into co-expressed genes and potential regulatory networks
Single-Cell RNA-Seq:
To resolve cellular heterogeneity within taste buds
Identifies co-expression patterns with other taste receptors and signaling components
This integrated approach has revealed that different Tas2r family members show variable expression patterns. For example, in mice, Tas2r113 showed higher expression in testis while exhibiting low to moderate expression in gustatory tissue , highlighting the importance of multi-tissue analysis for comprehensive characterization.
A systematic deorphanization approach for Tas2r113 should include:
Compound Library Preparation:
Establish a diverse bitter compound library (100-200 compounds)
Include natural bitter compounds, synthetic bitter molecules, and pharmacological agents
Test multiple concentrations (typically 3-300 μM) to establish dose-response relationships
Functional Assays:
Real-time calcium imaging: Monitor Ca²⁺ flux using fluorescent indicators (Fluo-4 AM)
FLIPR-based high-throughput screening for initial compound identification
Secondary validation with bioluminescence resonance energy transfer (BRET) assays
Expression System:
Transiently transfect HEK293T cells with Tas2r113 and Gα16gust44
Include positive controls (known broadly-tuned bitter receptors) and empty vector controls
Verify surface expression via immunocytochemistry or flow cytometry
Data Analysis:
Calculate EC₅₀ values for active compounds
Determine receptor tuning breadth by comparing the number of active compounds
Classify the receptor as specialist (narrow tuning) or generalist (broad tuning)
This methodological approach, similar to that used for other bitter taste receptors, has successfully identified agonists for 21 of 35 mouse Tas2r receptors, revealing variation in tuning breadth from specialists to generalists .
Tas2r113 exists within a complex evolutionary framework of bitter taste receptors:
Phylogenetic Classification:
Tas2r genes in vertebrates evolved through multiple gene duplication and diversification events
Rat Tas2r113 belongs to a rodent-specific cluster of bitter taste receptors that expanded after the divergence from primate lineages
Some Tas2r genes show clear one-to-one orthology between rodents and primates, while others (including Tas2r113) belong to species-specific expansions
Evolutionary Pressure:
Bitter taste receptors evolved primarily as defense mechanisms against potentially toxic compounds
Sequence analysis suggests many bitter receptors, including Tas2r113, have undergone positive selection, indicating adaptation to specific ecological niches
The gene's expression in non-gustatory tissues suggests potential secondary functions that emerged during evolution
Cross-Species Comparison:
While some Tas2r genes located on human chromosomes 5 and 7 and mouse chromosomes 2 and 15 exhibit one-to-one orthology, suggesting they developed prior to rodent-primate divergence , many others show species-specific patterns
These evolutionary differences highlight the importance of functional characterization rather than relying solely on sequence homology
Understanding Tas2r113's evolutionary context provides insights into its potential functions and helps predict which compounds might activate this receptor based on ecological relevance to rodents.
Evidence for extra-oral functions of Tas2r113 and related bitter taste receptors includes:
Expression Pattern Analysis:
Quantitative expression analyses have revealed Tas2r113 expression in non-gustatory tissues, with particularly high expression observed in rodent testis
This contrasts with its low to moderate expression in gustatory tissue, suggesting possible specialized roles in reproductive biology
Potential Physiological Roles:
Chemosensing: Detection of endogenous bitter compounds in internal tissues
Regulation of hormone secretion
Immune modulation
Metabolic regulation
Sperm function and fertilization
Research Implications:
Investigations should explore Tas2r113 signaling pathways in testicular cells
Knockout studies may reveal phenotypes unrelated to taste perception
Potential applications in reproductive biology and fertility research
Possible pharmacological targets for tissues expressing Tas2r113
The differential tissue expression pattern of Tas2r113 suggests that genetic regulation in taste papillae differs from that in other tissues , highlighting the need for tissue-specific research approaches when studying this receptor.
Researchers face several technical challenges when working with recombinant Tas2r113:
Expression Challenges:
Poor surface expression: Optimize with N-terminal signal sequences and chaperones
Protein misfolding: Test expression at lower temperatures (30°C instead of 37°C)
Toxic effects on host cells: Use inducible expression systems with tight regulation
Purification Challenges:
Low yield: Scale up production or optimize codon usage for expression host
Maintaining native conformation: Use mild detergents and avoid harsh elution conditions
Aggregation: Include stabilizing agents and optimize buffer conditions
Functional Assay Challenges:
Low signal-to-noise ratio: Increase sensitivity by using Gα16gust44 instead of Gα15
False negatives: Test broader concentration ranges and use multiple detection methods
Ligand solubility issues: Prepare proper stock solutions with appropriate vehicles
Quality Control Recommendations:
Verify protein identity by mass spectrometry and N-terminal sequencing
Confirm homogeneity by size-exclusion chromatography
Test functionality with known agonists of related receptors
Addressing these challenges requires systematic optimization and appropriate controls to ensure reliable and reproducible results when working with this challenging receptor.
Comprehensive validation of recombinant Tas2r113 requires multiple complementary approaches:
Biochemical Validation:
Western blot analysis using Tas2r113-specific antibodies
Size-exclusion chromatography to confirm monodispersity
Thermal stability assays to assess protein folding
Surface plasmon resonance to measure ligand binding
Functional Validation:
Calcium mobilization assays with known bitter compounds
Dose-response curves to determine EC₅₀ values
G protein coupling assays to confirm signal transduction
Comparison of responses to related Tas2r receptors
Specificity Controls:
Mutational analysis of key residues predicted to be involved in ligand binding
Competitive binding assays with known and novel ligands
Cross-reactivity testing with structurally related compounds
Negative controls using non-transfected cells or cells expressing empty vectors
Cross-Laboratory Validation:
Standardized assay protocols across different laboratories
Reference standards for quantitative comparisons
Blinded testing of compound libraries
These validation approaches ensure that observed responses are truly mediated by functional Tas2r113 rather than by endogenous receptors or non-specific effects, addressing the challenges of contradictory results often seen in bitter taste receptor research .